autologous Tcm cells immunotherapy

BIOLOGICAL2 trials

Sponsors

Beijing Huanxing Cancer Hospital, Beijing Friendship Hospital

Conditions

Carcinoma, Non-Small-Cell LungUrinary Bladder Neoplasm

Phase 2

Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma

TerminatedNCT03389438

Beijing Huanxing Cancer HospitalUrinary Bladder Neoplasm

Start: 2018-02-26End: 2021-10-31Updated: 2021-12-01

Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)

Beijing Friendship HospitalCarcinoma, Non-Small-Cell Lung

Start: 2018-04-03End: 2020-12-31Target: 68Updated: 2018-12-19